7.600USD-0.65%Mkt Cap: 785.74M USDP/E: —Last update: 2026-05-22
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like par…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap785.74M USD
Enterprise Value693.17M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-106.19M USD
Revenue/Share—
Last Price7.600 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees113
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.77
PEG—
EV/EBITDA-5.90
EV/Revenue—
P/S—
P/B4.58
EPS (TTM)-1.71
EPS (Forward)-2.03
52W Range
4.73060% of range9.535
52W High9.535 USD
52W Low4.730 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-77.56%
ROA-62.68%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-84.74M USD
CapEx (TTM)447.00K USD
FCF Margin—
FCF Yield-6.56%
Net Debt-97.74M USD
Net Debt/EBITDA0.83
Balance Sheet
Debt/Equity0.13
Current Ratio7.09
Quick Ratio6.87
Book Value/Sh1.672 USD
Cash/Share1.110 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)18.80 USD
Target Range15.00 USD – 24.00 USD
# Analysts5
Ownership
Shares Out.103.39M
Float93.38M
Insiders1.01%
Institutions51.03%
Short Interest
Short Ratio7.2d
Short % Float4.67%
Short % Out.3.42%
Shares Short2.19M
Short (prev mo.)2.62M
Technical
SMA 507.112 (+6.9%)
SMA 2006.233 (+21.9%)
Beta0.37
S&P 52W Chg28.31%
Avg Vol (30d)663.10K
Avg Vol (10d)625.83K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—